FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster

United States News News

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older.

A vial labelled with the Pfizer-BioNTech coronavirus disease vaccine is seen in this illustration picture taken March 19, 2021.

Dado Ruvic/IllustrationSept 17 - A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer IncReporting by Manojna Maddipatla in Bengaluru; Editing by Leslie AdlerSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightCOVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightJust in case you were wondering.
Read more »

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayFDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Read more »

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayFDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Read more »

FDA panel is first key test for Biden COVID-19 booster planFDA panel is first key test for Biden COVID-19 booster planGovernment advisers are debating whether to recommend extra doses of the Pfizer vaccine, a key step toward the Biden administration's plan to dispense COVID-19 booster shots. Scientists have been divided over the need for boosters and who should get them.
Read more »

FDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedFDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedThe Biden administration’s push to introduce widespread vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials.
Read more »

1 in 7 Dropped Friends Over COVID-19 Vaccine Views: Survey1 in 7 Dropped Friends Over COVID-19 Vaccine Views: SurveyAbout 1 in 7 Americans have ended friendships during the past year due to divided views over COVID-19 vaccines, according to a new survey.
Read more »



Render Time: 2025-02-25 19:16:12